Michael Cecchini

Michael Cecchini, MD

Yale University School of Medicine

Faculty

Biography

Dr. Michael Cecchini is an Associate Professor of Medicine (Medical Oncology) at the Yale Cancer Center in the Yale University School of Medicine. He is a board-certified medical oncologist that specializes in the treatment of patients with advanced gastrointestinal (GI) cancers. His research is focused on early phase clinical trials to develop novel therapies that are biomarker driven for patients with advanced gastrointestinal cancers. Furthermore, he performs translational research to better understand the relationship between DNA damage and the immune response to develop new biomarkers and treatment combinations for patients with advanced GI cancers. Dr. Cecchini is also the co-director of the Colorectal Cancer Program in the Yale Center for GI Cancers and is also a member of the National Cancer Institute Colon Task Force. Dr. Cecchini has served as an investigator on numerous clinical trials and has authored multiple manuscripts evaluating novel treatment combinations in advanced cancer.

Financial Disclosure

Seattle Genetics

Consultant

Taiho

Consultant

Regeneron

Consultant

Incendia Therapeutics

Consultant

Agenus

Consultant

Elevate Oncology

Consultant

LoxoLilly

Consultant

AstraZeneca

Consultant

Daiichi Sankyo

Consultant

Beigene

Consultant

Acus

Consultant

Modifi Bio

Consultant

Incyte

Consultant

Abbvie

Consultant

HiTOP

Consultant

Parabalis

Consultant

Wren Laboratories

Consultant

BainCapital

Consultant

Cybrexa

Consultant

Exelixis

Consultant

Takeda

Consultant